Years after Cubist buyout, Merck scores a new Zerbaxa indication. Can it jump-start sales?

Merck hasn’t exactly made a fortune on its $ 9.5 billion Cubist Pharmaceuticals buyout, but now, a next-gen antibiotic it acquired in that deal has a brand-new indication that could help jump-start sales. On Monday, the FDA approved that drug, Zerbaxa, to treat adults with hospital-acquired and ventilator-associated pneumonia. It’s an add-on to Zerbaxa’s original approvals—to treat complicated… Read More: Years after Cubist buyout, Merck scores a new Zerbaxa indication.… »

Why Oprah producer Sheri Salata had to quit to get healthy

When it came to dramatic health transformations, Sheri Salata knew every trick in the book. As the executive producer of “The Oprah Winfrey Show,” Salata, who grew up outside of Chicago, worked with the daytime-television queen for more than two decades. She had a “front row seat” to every diet trend, fitness craze and wackadoo… Read More: Why Oprah producer Sheri Salata had to quit to get… »

A Different ‘Game of Thrones’ Star Plays the Same Character in Both ‘Rocketman’ and ‘Bohemian Rhapsody’

Paramount/Getty Images/20th Century Fox John Reid may not be a name as embedded in the lore of popular music history as “Elton John” or “Queen,” but he’s a key figure in the story of both of those classic acts. And, weirdly enough, the cinematic connection of Reid—in last year’s Queen biopic Bohemian Rhapsody, and this… Read More: A Different ‘Game of Thrones’ Star Plays the Same Character… »

  1. Pages:
  3. 1
  5. 615
  6. 616
  7. 617
  8. 618
  9. 619
  10. 620
  11. 621
  13. 1820